These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2276702)

  • 41. Initiating potential of 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide (AF-2), butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT) and 3,3',4',5,7-pentahydroxyflavone (quercetin) in two-stage mouse skin carcinogenesis.
    Sato H; Takahashi M; Furukawa F; Miyakawa Y; Hasegawa R; Toyoda K; Hayashi Y
    Cancer Lett; 1987 Dec; 38(1-2):49-56. PubMed ID: 3690514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective effects of butylated hydroxyanisole and its analogs on the lung toxicity of butylated hydroxytoluene in mice.
    Mizutani T
    Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):125-33. PubMed ID: 4081305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estrogenic and anti-estrogenic activity of butylparaben, butylated hydroxyanisole, butylated hydroxytoluene and propyl gallate and their binary mixtures on two estrogen responsive cell lines (T47D-Kbluc, MCF-7).
    Pop A; Drugan T; Gutleb AC; Lupu D; Cherfan J; Loghin F; Kiss B
    J Appl Toxicol; 2018 Jul; 38(7):944-957. PubMed ID: 29460325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of phenolic antioxidants on the mutagenicity of aflatoxin B1.
    Shelef LA; Chin B
    Appl Environ Microbiol; 1980 Dec; 40(6):1039-43. PubMed ID: 7458309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose-related inhibition of aflatoxin B1 induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxyanisole and butylated hydroxytoluene.
    Williams GM; Tanaka T; Maeura Y
    Carcinogenesis; 1986 Jul; 7(7):1043-50. PubMed ID: 2872975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of forestomach lesions in rats by oral administrations of naturally occurring antioxidants for 4 weeks.
    Hirose M; Masuda A; Imaida K; Kagawa M; Tsuda H; Ito N
    Jpn J Cancer Res; 1987 Apr; 78(4):317-21. PubMed ID: 3108210
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modifying effects of concomitant treatment with butylated hydroxyanisole or butylated hydroxytoluene on N,N-dibutylnitrosamine-induced liver, forestomach and urinary bladder carcinogenesis in F344 male rats.
    Imaida K; Fukushima S; Inoue K; Masui T; Hirose M; Ito N
    Cancer Lett; 1988 Dec; 43(3):167-72. PubMed ID: 3203335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The urinary excretion of tritiated butylated hydroxyanisole and butylated hydroxytoluene in the rat.
    GOLDER WS; RYAN AJ; WRIGHT SE
    J Pharm Pharmacol; 1962 May; 14():268-71. PubMed ID: 13899745
    [No Abstract]   [Full Text] [Related]  

  • 49. Modification of gastrointestinal tumor development in rats by dietary butylated hydroxytoluene.
    Lindenschmidt RC; Tryka AF; Witschi H
    Fundam Appl Toxicol; 1987 May; 8(4):474-81. PubMed ID: 3609534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancement of tumor formation in mouse lung by dietary butylated hydroxytoluene.
    Witschi HP
    Toxicology; 1981; 21(2):95-104. PubMed ID: 7281206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic urticaria exacerbated by the antioxidant food preservatives, butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT).
    Goodman DL; McDonnell JT; Nelson HS; Vaughan TR; Weber RW
    J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 1):570-5. PubMed ID: 2229816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Butylhydroxyanisol (BHA), butylhydroxytoluene (BHT) and ethoxyquin (EMQ) tested for mutagenicity.
    Joner PR
    Acta Vet Scand; 1977; 18(2):187-93. PubMed ID: 327771
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of subsequent dehydroepiandrosterone, diaminopropane, phenobarbital, butylated hydroxyanisole and butylated hydroxytoluene treatment on the development of preneoplastic and neoplastic lesions in the rat initiated with di-hydroxy-di-n-propyl nitrosamine.
    Moore MA; Thamavit W; Tsuda H; Ito N
    Cancer Lett; 1986 Feb; 30(2):153-60. PubMed ID: 2937531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human cell cultures as an assay for the toxicity of antioxidants.
    Mochida K; Goto M; Saito K
    Bull Environ Contam Toxicol; 1985 Oct; 35(4):427-9. PubMed ID: 4052644
    [No Abstract]   [Full Text] [Related]  

  • 55. Microsome-mediated clastogenicity of butylated hydroxyanisole (BHA) in cultured Chinese hamster ovary cells: the possible role of reactive oxygen species.
    Phillips BJ; Carroll PA; Tee AC; Anderson D
    Mutat Res; 1989 Sep; 214(1):105-14. PubMed ID: 2770757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of benzidine mutagenesis by nucleophiles: a study using the Ames test with hamster hepatic S9 activation.
    Josephy PD; Carter MH; Goldberg MT
    Mutat Res; 1985; 143(1-2):5-10. PubMed ID: 3889604
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of butylated hydroxyanisole and butylated hydroxytoluene on 7,12-dimethylbenz[a]anthracene-DNA adduct formation in mouse embryo cell cultures.
    Sawicki JT; Dipple A
    Cancer Lett; 1983 Sep; 20(2):165-71. PubMed ID: 6421477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative pharmacokinetics of butylated hydroxyanisole and butylated hydroxytoluene in rabbits.
    El-Rashidy R; Niazi S
    J Pharm Sci; 1980 Dec; 69(12):1455-7. PubMed ID: 7463340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Noninhibitory effect of antioxidants ethoxyquin, 2(3)-tert-butyl-4-hydroxyanisole and 3,5-di-tert-butyl-4-hydroxytoluene on hepatic peroxisome proliferation and peroxisomal fatty acid beta-oxidation induced by a hypolipidemic agent in rats.
    Lalwani ND; Reddy MK; Qureshi SA; Moehle CM; Hayashi H; Reddy JK
    Cancer Res; 1983 Apr; 43(4):1680-7. PubMed ID: 6831413
    [No Abstract]   [Full Text] [Related]  

  • 60. Genotoxicity of phenolic antioxidants.
    Brusick D
    Toxicol Ind Health; 1993; 9(1-2):223-30. PubMed ID: 8418513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.